Induction Therapy With Anti-TNFa vs Cyclophosphamide in Severe Behçet Disease
Multicenter, Randomized, Prospective Trial Comparing the Efficacy and Safety of Infliximab to That of Cyclophosphamide in Severe Behçet's Disease. ITAC : Induction Therapy With Anti-TNFa vs Cyclophosphamide in Severe Behçet Disease Multicenter, Randomized, Prospective Trial Comparing the Efficacy and Safety of Infliximab to That o ...
Etude randomisée multicentrique évaluant l’efficacité et la tolérance de l’infliximab comparativement au Cyclophosphamide dans les formes sévères de maladie de Behçet Multicenter, randomized, prospective trial comparing the Efficacy and Safety of Infliximab to that of Cyclophosphamide in severe Behçet's disease - ITAC Etude randomisée multicentrique évaluant l’efficacité et la tolérance de l’infliximab comparativemen ...
Induction Therapy with Anti-TNF vs Cyclophosphamide in severe Behçet disease MedDRA version: 20.0;Level: LLT;Classification code 10004212;Term: Behcet's disease;System Organ Class: 100000017240 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Induction Therapy with Anti-TNF vs Cyclophosphamidein severe Behçet disease MedDRA version: 20.0;Lev ...